Enlivex Ltd.
ENLV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001596812
No open-market purchases or sales by Enlivex Ltd. insiders were filed in the last 90 days; 25 institutions reported holding it in 13F filings for Q2 2026, worth $2.34M in total; ARK Invest is the only superinvestor holding it.
13F holders, Q4 2022
Institutional positions in Enlivex Ltd. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- +4 vs. Q3 2022
- Shares held
- 338.0K
- +19.3K (+6.1%) vs. Q3 2022
- Total value
- $1.32M
- −$34.1K (−2.5%) vs. Q3 2022
- New holders
- 5
- 4 more added
- Sold out
- 1
- 6 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ENLV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 25 | $2.34M |
| Q1 2026 | 35 | $3.38M |
| Q4 2025 | 25 | $929.4K |
| Q3 2025 | 29 | $950.2K |
| Q2 2025 | 21 | $2.87M |
| Q1 2025 | 26 | $3.08M |
| Q4 2024 | 24 | $3.99M |
| Q3 2024 | 19 | $4.31M |
| Q2 2024 | 17 | $2.96M |
| Q1 2024 | 15 | $1.24M |
| Q4 2023 | 17 | $509.2K |
| Q3 2023 | 16 | $408.4K |
| Q2 2023 | 19 | $795.1K |
| Q1 2023 | 19 | $1.24M |
| Q4 2022 | 21 | $1.32M |
| Q3 2022 | 18 | $1.41M |
| Q2 2022 | 22 | $2.89M |
| Q1 2022 | 25 | $4.75M |
| Q4 2021 | 23 | $4.12M |
| Q3 2021 | 20 | $8.38M |
| Q2 2021 | 20 | $8.79M |
| Q1 2021 | 23 | $11.7M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Enlivex Ltd.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 98 | $0 | 0.00% | +98 | New |
| Sargent Bickham Lagudis LLC | 15 | $59 | 0.00% | +15 | New |
| Advisory Services Network, LLC | 43 | $168 | 0.00% | +43 | New |
| EWG Elevate Inc. | 100 | $394 | 0.00% | +100 | New |
| Red Tortoise LLC | 150 | $591 | 0.00% | +150 | New |
| Advisor Group Holdings, Inc. | 400 | $2.00K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 647 | $2.55K | 0.00% | −103−13.7% | Reduced |
| Barclays PLC | 1,000 | $3.94K | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 3,000 | $11.8K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 8,153 | $31.0K | 0.00% | +3,027+59.1% | Added |
| Geode Capital Management, LLC | 10,420 | $40.0K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 11,746 | $46.3K | 0.00% | −6,308−34.9% | Reduced |
| Edmond de Rothschild Holding S.A. | 13,000 | $50.7K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 13,499 | $52.6K | 0.00% | +13,015+2,689.0% | Added |
| Susquehanna International Group Ltd. | 18,887 | $72.1K | 0.03% | −1,412−7.0% | Reduced |
| Goldman Sachs Group Inc | 18,908 | $74.5K | 0.00% | −1,821−8.8% | Reduced |
| UBS Group AG | 33,445 | $131.8K | 0.00% | +1,574+4.9% | Added |
| Morgan Stanley | 40,726 | $160.4K | 0.00% | −3,790−8.5% | Reduced |
| Compagnie Lombard Odier SCmA | 50,000 | $190.0K | 0.01% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 54,189 | $213.0K | 0.00% | −4,700−8.0% | Reduced |
| Citadel Advisors LLC | 59,532 | $232.2K | 0.00% | +19,978+50.5% | Added |
| Umb Bank N A | 0 | $0 | 0.00% | −550−100.0% | Sold out |
| ACT Capital Management, LLC | – | – | – | – | Not filed |